Detection of monoclonal proteins in sera by capillary zone electrophoresis and free light chain measurements.

idemia. Arterioscler Thromb 1993;13:804–14. 5. Austin MA, McKnight B, Edwards KL, Bradley CM, McNeely MJ, Psaty BM, et al. Cardiovascular disease mortality in familial forms of hypertriglyceridemia. Circulation 2000;101:2777–82. 6. Pajukanta P, Nuotio I, Terwilliger JD, Porkka KVK, Ylitalo K, Pihlajamäki J, et al. Linkage of familial combined hyperlipidemia to chromosome 1q21–q23. Nat Genet 1998;18:369–73. 7. Wojciechowski AP, Farrall M, Cullen P, Wilson TM, Bayliss JD, Farren B, et al. Familial combined hyperlipidaemia linked to the apolipoprotein AI-CIII-AIV gene cluster on chromosome 11q23–q24. Nature 1991;349:161–4. 8. Dallinga-Thie GM, van Linde-Sibenius Trip M, Rotter J, Cantor RM, Bu X, Lusis AJ, et al. Complex genetic contribution of the Apo AI-CIII-AIV gene cluster to familial combined hyperlipidemia. J Clin Invest 1997;99:953–61. 9. Ribalta J, La Ville AE, Vallvé JC, Humphries SE, Turner PR, Masana L. A variation in the apolipoprotein C-III gene is associated with an increased number of circulating VLDL and IDL particles in familial combined hyperlipidemia. J Lipid Res 1997;38:1061–9. 10. Pennacchio LA, Olivier M, Hubacek JA, Cohen JC, Cox DR, Fruchart JC, et al. An apolipoprotein influencing triglycerides in humans and mice revealed by comparative sequencing. Science 2001;294:169–73. 11. van der Vliet HN, Groenink Sammels M, Leegwater ACJ, Levels JHM, Reitsma PH, Boers W, et al. Apolipoprotein V. J Biol Chem 2001;276: 44512–20. 12. Murphy M, Vilella E, Ceruelo S, Figuera L, Sánchez M, Camps J, et al. The MTHFR C677T, APOE, and PON55 polymorphisms show relevant interactions with cardiovascular risk factors. Clin Chem 2002;48:372–5. 13. Castro Cabezas M, Halkes CJM, Meijssen S, van Oostrom AJHHM, Erkelens DW. Diurnal triglyceride profiles: a novel approach to study triglyceride changes. Atherosclerosis 2001;155:219–28.